Our products
Addressing unmet patient needs in oncology
Our medicine is approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. Product availability, name and indication may vary by country. Always ask a healthcare professional for advice about medicines.
To report negative side effects of prescription drugs to the FDA, visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
USA
KIMMTRAK (tebentafusp-tebn)
(Injection for Intravenous Use 100 mcg/0.5 mL)
- U.S. Full Prescribing Information including Boxed WARNING for CRS
- U.S. Patient Information including BOXED WARNING for CRS
- Information for Colorado Prescribers of Prescription Drugs
- U.S. Product website
You are leaving www.immunocore.com, a website provided by Immunocore Ltd. This link will take you to the product-specific site that is intended for residents of the US. Click Cancel to return to Immunocore.com or Click OK to continue to this product-specific site.
GB
KIMMTRAK (tebentafusp)
(Concentrate for Solution for Infusion 200 mcg/mL)
EU
KIMMTRAK (tebentafusp)
(Concentrate for Solution for Infusion 100 mcg/0.5 mL)